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Introduction {#s1}
============

According to the World Health Organization (WHO) report, about 395,000 deaths have occurred from all causes in Iran in 2012, of which 76% account for non- communicable diseases ([@R1]). Premature mortality imposes significant economic burden on the society in different aspects ([@R2]). There are many approaches to estimate the economic burden of diseases and its consequences. One of the most important approaches is the cost of illness (COI) studies ([@R3],[@R4]). In COI studies, total cost is divided by direct costs and indirect costs. Direct cost consists of healthcare costs (hospitalization, medicine, visits, etc) and non-healthcare costs (transport, food, etc). Indirect costs include morbidity cost (absenteeism from work, early retirement) and mortality cost (lost productivity due to premature deaths) ([@R2],[@R5]-[@R9]). Based on this perspective, the inclusion or exclusion of these costs is different. The comprehensive perspective is the societal perspective, in which both direct and indirect costs are considered ([@R7],[@R10]). Several studies have found that mortality costs account for the largest proportion of the total cost. Therefore, it is necessary to quantify disease-related mortality in financial terms to make a better estimation for resource allocation and policy/decision making ([@R11],[@R12]).

Thus, it is important to quantify the value of labor productivity loss due to premature mortality in measuring the economic burden of diseases ([@R2],[@R3]).  Quantification of the lost productivity due to premature mortality is useful for interpreting economic burden of diseases and predicting costs to the society ([@R13]). In addition, this helps the policy-makers to set the disease control priorities and design effective preventive interventions to reduce burden of diseases and mortalities ([@R14]-[@R16]). That is why cost analysis is one of the top first five areas of research priorities ([@R17]). Although a few related studies had been conducted in Iran, they only focused on DALYs ([@R18],[@R19]) and cancer productivity losses ([@R20]). Moreover, economic burden of premature mortality on productivity loss attributed to most important causes of death have not been yet estimated in Iran at the national level, and no overall picture of lost productivity due to leading causes of death is available.

Therefore, this study aimed to estimate the years of potential life lost (YPLL), years of potential productive life lost (YPPLL) and the cost of productivity lost (CPL) due to premature mortality caused by five leading causes of death in Iran over a five-year period from 2006 to 2010.

Methods {#s2}
=======

General Approach {#s2-0-1}
----------------

Based on previous studies ([@R3],[@R7],[@R20],[@R21]), the Human Capital Approach was used to estimate the cost of lost productivity due to five leading causes of premature mortality in Iran from 2006 to 2010. To estimate the burden of these diseases, three measures of years of potential life lost (YPLL), years of potential productive life lost (YPPLL) and the cost of lost productivity (CLP) due to premature mortality were used. These measures focus on the social and economic impact of premature mortality ([@R20],[@R22],[@R23]). To estimate the YPLL and CPL, we used life expectancy method and working age (from 15 to 65 years), respectively.

Data Sources {#s2-0-2}
------------

Data on mortality by sex and age groups for 29 provinces (data on Tehran province was not available) were obtained from the Ministry of Health and Medical Education (MoHME) ([@R24]). The database contains number of deaths due to all causes by sex and 5-year age- groups (including under one, 1-4, 5-9, 10-14, 15-19, 20-24, 24-29, 30-34, 35-39, 40- 44, 45-49, 50-59. 60-64, 65-69, 70- 74, 75-79, 80-84 and 85+). To achieve the purpose of the study, we extracted data on five leading causes of premature mortality. Number of deaths during 2005-2009 in all age groups was used to calculate YPLL. To estimate the cost of productivity loss, number of deaths between the ages of 15 and 64 was extracted from the database, using the International Classification of Diseases (ICD) codes (A00- Y98). To estimate the average life expectancy for each age group, Iran life table from the World Health Organization was used ([@R25]). Data on age- and sex-specific wages came from the Iranian Ministry of Cooperation Labor and Social Welfare. In addition, the data on age and sex-specific employment and housekeeping rate for the study period were obtained from the Iranian Statistical Center (ISC) ([@R26]). Based on the mean economic growth in the past 30 years in Iran, 3.7% was considered in the study ([@R26]).

Estimation Methods {#s2-0-3}
------------------

YPLL Estimation Due to Premature Mortality: To estimate YPLL for premature mortality due to five leading causes of deaths, we assumed that all the deaths in each age group occurred in the mid-point of that age group. To calculate YPLL, the number of deaths in each age group was multiplied by the average of the remaining life expectancy for that age group. The number of YPLL was calculated as follows ([@R27]):

$$YPLL = {\sum\limits_{i = 0}^{\infty}{di \times Li}}$$

Where d~i~ is the number of deaths at the mid-point of each age group; i, and L~i~ is the average of remaining life expectancy for that age group i.

Cost of Productivity Lost due to Premature Mortality: First, we estimated years of potential productive life lost (YPPLL). YPPLL estimation is similar to YPLL estimation, but to calculate YPPLL, all deaths below 15 and above 65 years (the retirement age in Iran) were disregarded. Second, YPPLL was calculated by multiplying the number of cause-specific deaths for a given age group by the expected remaining productive life years (until retirement age) at the mid-point for each age group. The number of YPPLL was calculated as follows ([@R27]):

$$YPPLL = {\sum\limits_{i = 0}^{N}{di \times (W_{U} - W_{L})}}$$

Where d~i~ is the number of deaths at the mid-point of each age group; i, W~U~ is the upper limit of working age (65 years), and W~L~ is the lower working age (from 15 to 65).

Third, the calculated YPPLL was multiplied by age and sex-specific annual wages from age of deaths until the retirement age. The estimated costs of lost productivity were adjusted based on the employment and housekeeping rate. Moreover, to obtain the present value, the future costs were discounted at 3% per year. Cost of productivity loss for each death was summed across age groups by sex and cause of death.

Results {#s3}
=======

Based on our data, 1,283,372 deaths occurred due to all causes in Iran from 2006 to 2011 (excluding Tehran province); of which, 40% (518,815) were attributable to five main leading causes of death. Moreover, 58% of the total deaths due to five main leading causes were in males; 260,767 deaths were due to myocardial infarction (MI), 127,301 to cerebral vascular diseases (CVD), 59,231 to transport accidents (TA), 43,474 to hypertensive heart disease (HHD) and 28,042 were due to gastric cancer (GC) ([Table 1](#T1){ref-type="table"}).

###### The Number of Deaths due to Five Leading Causes by Sex in Iran during 2006-2010

  --------- ---------------------------- -------- -------- -------- -------- --------
  ICD COD   Cause                        2006     2007     2008     2009     2010
  Male                                                                       
  C16       Gastric cancer               3,680    3,790    3,777    3,740    3,735
  I11       Hypertensive heart disease   3,671    4,375    4,393    4,098    4,295
  I20-I25   Myocardial infarction        30,336   29,501   28,691   29,941   30,938
  I60-I69   Cerebral vascular diseases   13,564   13,403   12,983   12,934   13,021
  V01-V99   Transport accidents          12,064   9,581    8,655    8,948    7,990
  Total                                  63,315   60,650   58,499   59,661   59,979
  Female                                                                     
  C16       Gastric cancer               1,849    1,905    1,824    1,853    1,889
  I11       Hypertensive heart disease   4,131    4,761    4,661    4,392    4,697
  I20-I25   Myocardial infarction        22,372   21,828   22,100   22,049   23,011
  I60-I69   Cerebral vascular diseases   12,433   12,749   12,495   11,649   12,070
  V01-V99   Transport accidents          2,974    2,440    2,240    2,363    1,976
  Total                                  43,795   43,683   43,320   42,306   43,643
  --------- ---------------------------- -------- -------- -------- -------- --------

There were 350, 055 working-age (15-64) deaths related to these five main causes between 2006 and 2010. Of these deaths, 172,216 were due to MI, 76,340 to CVD, 55 088 to TA, 24,423 to HHD and 21,988 due to GC.

For both sexes, the highest number of the YPLL was related to MI, followed by CVD, TA, HHD, GC, respectively ([Table 2](#T2){ref-type="table"}). These five leading causes of death resulted in 461,076,890 YPLL in total, 274,560,022 (59.5%) in males and 186,516,868 (40.5%) in females. From 2006 to 2010, the overall number of YPLL decreased by 8%.

###### Estimated YPLL for Five Main Causes by Sex in Iran during 2006-2010

  --------- ---------------------------- ------------ ------------ ------------ ------------ ------------
  ICD COD   Cause                        2006         2007         2008         2009         2010
  Male                                                                                       
  C16       Gastric cancer               3,452,435    3,556,324    3,497,347    3,474,500    3,460,583
  I11       Hypertensive heart disease   3,001,086    3,566,476    3,502,377    3,243,086    3,375,947
  I20-I25   Myocardial infarction        27,368,890   26,404,177   25,324,677   26,397,891   26,824,894
  I60-I69   Cerebral vascular diseases   10,943,567   10,620,892   10,060,298   10,184,364   10,036,975
  V01-V99   Transport accidents          14,395,032   11,372,877   10,298,047   10,630,598   9,566,669
  Total                                  59,161,010   55,520,746   52,682,746   53,930,439   53,265,068
  Female                                                                                     
  C16       Gastric cancer               1,878,243    1,942,208    1,844,060    1,825,545    1,910,794
  I11       Hypertensive heart disease   3,445,412    3,882,685    3,767,671    3,548,044    3,726,028
  I20-I25   Myocardial infarction        19,465,490   18,719,733   18,752,869   18,651,951   19,183,013
  I60-I69   Cerebral vascular diseases   10,362,611   10,575,275   10,191,173   9,475,783    9,589,670
  V01-V99   Transport accidents          3447995      2797873      2537043      2722637      2273052
  Total                                  38,599,751   37,917,774   37,092,816   36,223,960   36,682,557
  --------- ---------------------------- ------------ ------------ ------------ ------------ ------------

[Table 3](#T3){ref-type="table"} demonstrates the number of YPPLL by cause and sex. The estimated YPPLL resulted in 209,552,135 YPPLL from 2006 to 2011; of them, 141,966,592 (67%) were in males and 67,585,543 (33%) were in females. From 2006 to 2010, the total number of YPPLL decreased by 13%.

###### Estimated YPPLL for the Five Main Causes of Death by Sex in Iran during 2006-2010

  --------- ---------------------------- ------------ ------------ ------------ ------------ ------------
  ICD COD   Cause                        2006         2007         2008         2009         2010
  Male                                                                                       
  C16       Gastric cancer               1,536,114    1,637,184    1,549,353    1,614,315    1,644,043
  I11       Hypertensive heart disease   1,016,289    1,205,569    1,157,608    1,090,266    1,131,258
  I20-I25   Myocardial infarction        12,592,092   12,262,663   11,786,048   12,369,898   12,571,810
  I60-I69   Cerebral vascular diseases   3,547,362    3,394,198    3,107,399    3,496,572    3,312,210
  V01-V99   Transport accidents          12784,833    1,0036,911   9,159,396    9,444,637    8,518,566
  Total                                  31,476,690   28,536,525   26,795,804   28,015,688   27,177,887
  Female                                                                                     
  C16       Gastric cancer               912,613      977,750      908,019      870,993      991,512
  I11       Hypertensive heart disease   939,237      1,041,103    1,020,587    1,017,053    990,363
  I20-I25   Myocardial infarction        6,618,507    6,194,778    6,302,392    6,460,854    6,481,836
  I60-I69   Cerebral vascular diseases   3,050,543    3,177,438    2,937,198    2,796,614    2,698,931
  V01-V99   Transport accidents          2,816,288    2,248,559    2,046,933    2,232,546    1,852,895
  Total                                  14,337,188   13,639,628   13,215,129   13,378,060   13,015,537
  --------- ---------------------------- ------------ ------------ ------------ ------------ ------------

The total cost of lost productivity caused by premature deaths due to five leading causes was 7.86 billion dollars (US\$) from 2006 to 2010, ranging from 1.63 billion dollars in 2006 to 1.31 billion dollars in 2010, and it decreased by 0.8% in this period. The main contributors of the total cost of productivity lost were transport accidents, myocardial infarction, cerebral vascular diseases, gastric cancer and hypertensive heart disease, respectively. The percentage of the total costs due to productivity losses for the five leading causes of death was 91.2% in males and 8.8% in females ([Table 4](#T4){ref-type="table"}).

###### Estimated Premature Mortality Costs due to the Five Leading Causes of Death by Sex in Iran during 2006-2010, (US \$)

  --------- ---------------------------- --------------- --------------- --------------- --------------- ---------------
  ICD COD   Cause                        2006            2007            2008            2009            2010
  Male                                                                                                   
  C16       Gastric cancer               39,005,208      46,647,752      45,482,655      50,260,028      43,152,544
  I11       Hypertensive heart disease   22,729,431      27,582,467      30,833,206      31,279,646      28,074,504
  I20-I25   Myocardial infarction        345,022,647     345,022,650     410,219,144     451,221,205     370,786,268
  I60-I69   Cerebral vascular diseases   96,805,400      97,026,445      106,037,549     132,087,684     100,528,127
  V01-V99   Transport accidents          99,8547,905     829,297,422     912,928,738     937,923,785     682,108,151
  Total                                  1,502,110,591   1,345,576,736   1,505,501,292   1,602,772,348   1,224,649,594
  Female                                                                                                 
  C16       Gastric cancer               893,155         9,142,011       9,378,496       9,473,632       7,482,980
  I11       Hypertensive heart disease   5,675,311       6,514,238       7,955,501       7,724,154       5,715,652
  I20-I25   Myocardial infarction        46,435,456      47,654,162      57,944,378      65,476,405      49,604,550
  I60-I69   Cerebral vascular diseases   20,459,375      25,067,205      27,213,372      27,440,535      19,115,364
  V01-V99   Transport accidents          57,203,705      51,740,998      54,180,119      60,075,293      4,922,391
  Total                                  130,667,002     140,118,614     156,671,866     170,190,019     86,840,937
  --------- ---------------------------- --------------- --------------- --------------- --------------- ---------------

The average premature mortality cost per cause for both sexes combined was \$172,906 in the study period, which was \$273,838 for males and \$71,975 for females. In this period, the most costly cause per death in both sexes combined was transport accidents (\$72,571 per death), followed by myocardial infarction (\$ 27,212). However, the least costly cause in both sexes was hypertensive heart disease (\$33 701 for male vs. \$9 337 for female). [Table 5](#T5){ref-type="table"} demonstrates the average premature mortality cost per YPPLL by sex from 2007 to 2010. The cost per YPPLL for both sexes combined was \$25.4 in the study period, and it was \$40.8 for males and \$10.1 for females from 2006 to 2010. In term of cost per YPPLL, like cost per death, transport accidents and myocardial infarction were the most and least costly causes, respectively.

###### Premature Mortality Costs Per Death/YPPLL for the Five Leading Causes of Death in Iran, 2006-2010, (US \$)

  ---------------------------- ----------- --------- --------- --------- --------- ---------
  Cause                                    2006      2007      2008      2009      2010
  Male                                                                             
  Gastric Cancer               CPL/DEATH   34,366    38,776    39550     41,988    35,575
  CPL/YPPLL                    25.4        28.5      29.3      31.1      26.3      
  Hypertensive Heart Disease   CPL/DEATH   30,065    30,887    35,769    38,521    33,263
  CPL/YPPLL                    22.4        22.9      26.6      28.7      24.8      
  Myocardial infarction        CPL/DEATH   37,539    38,442    47,539    49,836    40,176
  CPL/YPPLL                    27.4        28.1      34.8      36.5      29.5      
  Cerebral vascular diseases   CPL/DEATH   36,808    38,502    45,883    50,842    40,749
  CPL/YPPLL                    27.3        28.6      34.1      37.8      30.4      
  Transport accidents          CPL/DEATH   103,358   109,521   131,907   132,120   107,199
  CPL/YPPLL                    78.1        82.6      99.7      99.3      80        
  Female                                                                           
  Gastric Cancer               CPL/DEATH   1,397     13,463    14,769    15,404    10,720
  CPL/YPPLL                    0.1         9.4       10.3      10.9      7.5       
  Hypertensive heart disease   CPL/DEATH   8,508     8,685     10,927    10,581    7,982
  CPL/YPPLL                    6           6.3       7.8       7.6       5.8       
  Myocardial infarction        CPL/DEATH   9,879     10,803    12,902    14,240    10,762
  CPL/YPPLL                    7           7.7       9.2       10.1      7.6       
  Cerebral vascular diseases   CPL/DEATH   9,450     11,106    12,971    13,761    9,950
  CPL/YPPLL                    6.7         7.9       9.3       9.8       7         
  Transport accidents          CPL/DEATH   28,803    32,789    37,756    38,435    3,821
  CPL/YPPLL                    20.3        23        26.5      26.9      2.6       
  ---------------------------- ----------- --------- --------- --------- --------- ---------

Discussion {#s4}
==========

The purpose of this study was to quantify the economic burden of five main causes of premature mortality in Iran between 2006 and 2011. It was measured by mortality, YPLL, YPPLL and cost of lost productivity. To estimate the cost of lost productivity, we used the human capital approach, the most commonly used method in the literature ([@R3],[@R6],[@R7],[@R20],[@R28],[@R29]).

The majority of the previous studies have estimated the productivity costs that focused on one cause or disease ([@R2],[@R3],[@R5],[@R13],[@R20],[@R21],[@R28]-[@R32]) that may not have necessarily been conducted on the leading cause of death. However, in this study, we considered five main causes of deaths in Iran from 2006 to 2010. Several studies were conducted in Iran; of which, two estimated the burden of diseases by DALYs ([@R18],[@R19]), and others estimated cancer related lost productivity ([@R20],[@R32]). Based on our results, average deaths per year was 256, 674 during 2006-2010. The study of Forouzanfar et al. showed that almost 350,000 deaths occurred in Iran in all age groups and both sexes in 2010 ([@R18]). One reason for this difference may be due to the unavailabity of the data on Tehran province, which constitutes a large porportion of Iran's population. About 518,815 (40%) of deaths occured due to the five main causes in Iran from 2006 to 2010; of which, 58% were in males. MI, CVD and TA were the three leading causes of deaths in both sexes. This finding is similar to the findings of previous studies in Iran that reported road injuries and ischemic heart disease as the two main causes of death in both sexes ([@R18],[@R19]).

This study indicated that main contributors to YPLL in both sexes were MI, CVD, TA, HHD, GC, respectively. This finding is in line with the report of above mentioned studies that reported ischemic heart disease and road injuries were two of the main contributors to DALYs ([@R18],[@R19]). Furthermore, a systematic analysis for the Global Burden of Disease (GBD) study by Lozano et al. showed that ischaemic heart disease, cerebro vascular disease and road injury were three of the 10 leading causes of both death and years of life lost due to premature mortality (YLLs) at the global level and for any region in the world in 2010 ([@R15]). In addition, a peviously mentioned report showed that stomach cancer and hypertensive heart disease are two of the 25 leading causes of YPLL at the global and regional level ([@R15]). The findings of this study revealed that the total number of YLLs from transport accidents decreased by 34%, but increased by 10% for ischemic heart disease for both sexes combined durig 2006-2010. The 34% reduction in YPLL in TA may imply the following two points: First, the health system of Iran has provided better curative and rehabilative interventions for injured idividuals. Second, this may be due to the fact that the reduction injuries policies of the goverment has had good outcomes. Rezaei et al. found a significant negative relatioship between number of physicians per 10,000 population and deaths from road traffic crashes in Iran ([@R30]). Second, a share of prevented cost of premature mortality (YPLL) probably shifted to cost of morbidity (years lived with disability (YLD)). For example, a saved injured individual from death (YPLL) may experience absenteeism from work or early retirement ([@R2],[@R5],[@R7],[@R8]) or both.

Our findings revealed that the total productivity costs from premature mortality were about US\$ 7.86 billion between 2006 and 2010, and averege productivity cost per year was US\$1.57 billion for both sexes combined. This study revealed a higher total cost of premature mortality in males (\$7,1 billion vs. \$684 million) during 2006-2010, and this difference was due to higher mortalitiy, employment and wage rate for males. The findings of a previous study in Iran showed that the total cost of premature cancer-related mortality for males was 67% higher than females([@R20]). Furthurmore, in Ireland and the United States, it was 90% and 80% times higher in the males, respectively ([@R3],[@R30]).

This study showed that TA was the most costly cause in males, females and both sexes, implying that the majority of deaths that have occurred due to TA were near lower limits of the working-age range, which resulted in higher YPLL. Therefore, its productivity cost losses is higher than the other causes. The ranking of causes by type of mesures was different; for instance, TA ranked 3rd in terms of YPLL and 1st in terms of CPL and CPL per YPPLL. These changes depend on age of death for each cause and survival rate. When a cause or disease with low survival rate results in death in a young age, it generally receives higher rank of YPLL per death and cost per death ([@R3],[@R20],[@R30]).

This study had some limitations; therefore, interpreting the results should be made with causion. First, our analysis was based on data on 29 provinces of Iran, with no data on Tehran province, meaning that a large percentage of deaths were not included in the study. The second limitation was the lack of data on deaths and diseases at the national level in Iran. Moreover, there was a remarkable underestimation of mortality data in Iran ([@R18]). The third limitation was that this study estimated productivity losses due to premature mortality; and therefore, other productivity losses such as absenteeism from work, early retirement and reduction in employment were not considered.

Conclusion {#s5}
==========

Estimating productivity losses in monetary term provides an overall picture of economic burden of diseases, which may be useful for health system policy makers to design effective interventions and priority-based resource allocation, specially during times of constrained resourses. This study revealed that the economic burden of premature mortalities due to the five main causes of death is substantial, which was about \$7.86 billion during 2006-2010 in Iran. In this period, the overall cost of productivity losses for the males was 10.5 times higher than the females. Our results also showed that transport accidents and myocardial infraction were the most costly cases in term of the total cost. In summary, these five leading causes of death, specially transport accidents and myocardial infraction, should be considered in prevention programms.

The allocation of financial resources to control these causes can decrease their economic burden and may result in higher level of health and well-being.
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